Advertisement

Human Genetics

, Volume 73, Issue 4, pp 320–326 | Cite as

A routine method for the establishment of permanent growing lymphoblastoid cell lines

  • Heidemarie Neitzel
Original Investigations

Summary

Permanent lymphoblastoid cell lines are of great practical value in human clinical and experimental genetics. A detailed protocol for routine use is given for the establishment of lymphoblastoid lines from peripheral blood using Esptein-Barr virus and the immunosuppressivum Cyclosporin A. In addition, the biologic basis of this transformation system is briefly summarized.

Keywords

Internal Medicine Cyclosporin Metabolic Disease Transformation System Biologic Basis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aya T, Osato T (1974) Early events in transformation of human cord leukocytes by Epstein-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis. Int J Cancer 14:341–347Google Scholar
  2. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211Google Scholar
  3. Bird AG, McLachlan SM, Britten S (1981a) Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 289:300–301Google Scholar
  4. Bird AG, Britten S, Ernberg I, Nilsson K (1981b) Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med 154:832–839Google Scholar
  5. Bodescot M, Chambraud B, Farrell P, Perricaudet M (1984) Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO J 3: 1913–1917Google Scholar
  6. Brack C, Mattaj IW, Gautschi J, Cammisuli S (1984) Cyclosporin A is a differential inhibitor of eukaryotic RNA polymerases. Exp Cell Res 151:314–321Google Scholar
  7. Cohen LK, Speck SH, Roberts BE, Strominger JL (1984) Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc Natl Acad Sci USA 81:4183–4187Google Scholar
  8. Dambaugh T, Beisel C, Hummel M, King W, Fennewald S, Cheung A, Heller M, Raab-Traub N, Kieff E (1980) Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci USA 77:2999–3003Google Scholar
  9. Einhorn L, Ernberg I (1978) Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer 21:157–160Google Scholar
  10. Henderson E, Miller G, Robinson J, Heston L (1977) Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 76:152–163Google Scholar
  11. Henderson A, Ripley S, Heller M, Kieff E (1983) Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 80:1987–1991Google Scholar
  12. Ikeuchi T (1984) Inhibitory effect of ethidium bromide on mitotic chromosome condensation and its application to high-resolution chromosome banding. Cytogenet Cell Genet 38:56–61Google Scholar
  13. Issekutz T, Chu E, Geha RS (1982) Antigen presentation by human B cells: T cell proliferation induced by Epstein-Barr virus B lymphoblastoid cells. J Immunol 129:1446–1450Google Scholar
  14. James SP, Yenokida GG, Graeff AS, Strober W (1982) Activation of suppressor T cells by autologous lymphoblastoid cells: a mechanism for feedback regulation of immunoglobulin synthesis. J Immunol 128:1149–1154Google Scholar
  15. Kirchner H, Tosato G, Blaese RM, Broder S, Magrath IT (1979) Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol 122:1310–1313Google Scholar
  16. Klein G, Sugden B, Leibold W, Menezes J (1974) Infection of EBV-genome-negative and positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology 3:232–244Google Scholar
  17. Krönke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC (1984) Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 81:5214–5218Google Scholar
  18. Miller G (1984) Epstein-Barr virus—immortalization and replication. N Engl J Med 310:1255–1256Google Scholar
  19. Miller G, Lipman M (1973) Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med 138:1398–1412Google Scholar
  20. Moss DJ, Rickinson AB, Pope JH (1978) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662–668Google Scholar
  21. Moss DJ, Rickinson AB, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23:618–625Google Scholar
  22. Moss DJ, Rickinson AB, Wallace LE, Epstein MA (1981) Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature 291:644–666Google Scholar
  23. Nowell PC (1960) Phytohemagglutinin: An indicator of mitosis in cultures of normal human leukocytes. Cancer Res 20:462–466Google Scholar
  24. Palacios R (1981) Cyclosporin A abrogates proliferation of T cells and generation of suppressor and cytotoxic T-cell function induced by Epstein-Barr virus. Immunbiology 160:321–329Google Scholar
  25. Pattengale PK, Smith RW, Gerber P (1973) Selective transformation of B lymphocytes by EB virus. Lancet II:93–94Google Scholar
  26. Pizzo PA, Magrath IT, Chattopadhyay SK, Biggar RJ, Gerber P (1978) A new tumor-derived transforming strain of Epstein-Barr virus. Nature 272:629–631Google Scholar
  27. Rabin H, Neubauer RH, Hopkins RF, Nonoyama M (1978) Further characterization of a Herpes virus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate Herpes viruses. Int J Cancer 21:762–767Google Scholar
  28. Rickinson A (1984) Epstein-Barr virus in epithelium. Nature 310:99Google Scholar
  29. Rickinson AB, Moss DJ, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23:610–617Google Scholar
  30. Rickinson AB, Moss DJ, Allen DJ, Wallace LE, Rowe M, Epstein MA (1981) Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int J Cancer 27:593–601Google Scholar
  31. Robinson J, Smith D (1981) Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis. Virology 109:336–343Google Scholar
  32. Robinson J, Frank A, Henderson E, Schweitzer J, Miller G (1979) Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr virus. Infect Immun 26:225–231Google Scholar
  33. Schneider U, zur Hausen H (1975) Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer 15:59–66Google Scholar
  34. Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS (1980) Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cell Immunol 56:518–525Google Scholar
  35. Sixbey JW, Vesterinen EH, Nedrud JG, Raab-Traub N, Walton LA, Pagano JS (1983) Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306:480–483Google Scholar
  36. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230Google Scholar
  37. Steel CM, Philipson J, Arthur E, Gardiner SE, Newton MS, McIntosh RV (1977) Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature 270:729–730Google Scholar
  38. Sugden B, Mark W (1977) Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 23:503–508Google Scholar
  39. Sudgen B, Phelps M, Domoradzki J (1979) Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31:590–595Google Scholar
  40. Szigeti R, Sulitzeanu D, Henle G, Henle W, Klein G (1984) Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Proc Natl Acad Sci USA 81:4178–4182Google Scholar
  41. Takadá K, Osato T (1979) Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis. Intervirology 11:30–39Google Scholar
  42. Tanaka Y, Sugamura K, Hinuma Y, Sato H, Okochi K (1980) Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropositive adults as revealed by an in vitro restimulation method. J Immunol 125:1426–1431Google Scholar
  43. Tosato G, Pike SE, Koski IR, Blaese RM (1982a) Selective inhibition of immunoregulatory cell functions by Cyclosporin A. J Immunol 128:1986–1991Google Scholar
  44. Tosato G, Magrath IT, Blaese RM (1982b) T cell-mediated immunoregulation of Epstein-Barr virus (EBV)-induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol 128:575–579Google Scholar
  45. Tsukuda K, Tsukuda Y, Klein G (1982) Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines. Cell Immunol 69:291–304Google Scholar
  46. Werner J, Henle G, Pinto CA, Haff RF, Henle W (1972) Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar). Int J Cancer 10:557–567Google Scholar
  47. Wolf H (1984) Epstein-Barr virus and carcinoma. Nature 312:705Google Scholar
  48. Wolf H, Haus M, Wilmes E (1984) Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795–798Google Scholar
  49. Yamamoto K, Mizuno F, Matsuo T, Tanaka A, Nonoyama M, Osato T (1978) Epstein-Barr virus and human chromosomes: close association of the resident viral genome and the expression of the virus-determined nuclear antigen (EBNA) with the presence of chromosome 14 in human-mouse hyrid cells. Proc Natl Acad Sci USA 75:5155–5159Google Scholar
  50. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806–3810Google Scholar
  51. Yunis JJ, Sawyer JR, Ball DW (1978) The characterization of highresolution G-banded chromosomes of man. Chromosoma 67: 293–307Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • Heidemarie Neitzel
    • 1
  1. 1.Institut für HumangenetikFreie Universität BerlinBerlin-West 19Germany

Personalised recommendations